We have prepared this document,“Sublingual Immunotherapy: World Allergy Organization
Position Paper 2013 Update”, according to the evidence-based criteria, revising and …

Sublingual immunotherapy (SLIT) has been used with increasing frequency in Europe and
is viewed with increasing interest by allergists in the United States. To address this interest …

Background Subcutaneous allergen immunotherapy (SCIT) and sublingual allergen
immunotherapy (SLIT) are safe and effective treatments of allergic rhinitis, but high levels of …

Sublingual immunotherapy (SLIT) has gained wide accep-tance in many European
countries and has raised the level of interest in immunotherapy among practicing allergists …

BACKGROUND: Sublingual immunotherapy is well tolerated and data suggest its
effectiveness for the treatment of allergic rhinitis in adults, but it lacks optimum dose …

The Allergic Rhinitis and its Impact on Asthma document was first published in 2001. Since
then, new data on specific immunotherapy have appeared. This review is intended as an …

Some of the patients had more than 1 SLIT prescription, but none of them discontinued a
single treatment only; thus, the percentages were unaffected. There was no difference …

Appeared at the beginning of the 20th century, allergen-specific immunotherapy (SIT) has
long been used in allergic rhinitis and asthma without any knowledge of its mechanisms of …

Studies addressing the adherence to allergen-specific immunotherapy in literature are
lacking. In real life, costs and patient education are crucial issues in conditioning adherence …

BACKGROUND: Although research demonstrates that allergy immunotherapy (IT) improves
allergic rhinitis (AR) outcomes, little is known about IT patterns of care and associated …